Clinical TrialsSearch results
Number of results: 337
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Searching research on senior citizen's gastric cancer on clinical effect and safety of TS-1
- senior citizen's gastric cancer
- The Tokyo cooperative Oncology Group
- 2005-11-18
Other
- Safety of Biologics in Clinical Use in Japanese Patients with Rheumatoid Arthritis in Long-Term (SECURE)
- Rheumatoid Arthritis
- Japan College of Rheumatology
- 2008-09-01
Other
- Routine use of debris aspiration before retrieval of filter protection devices in carotid arterial stenting: Analysis of debris captured by filter device and aspiration
- Carotid artery stenosis
- Department of Neurosurgery, Brain Research Institute, University of Niigata
- 2009-04-01
Other
- Rituximab + standard CHOP (R S-CHOP) vs Rituximab + bi-weekly CHOP (R Bi-CHOP) RCT(phase II/III) low-grade B-cell lymphoma at advanced stage (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
- Untreated CD20-positive low-grade B-cell lymphoma at advanced stage
- Japan Clinical Oncology Group(JCOG)
- 2005-07-30
Recruiting
- RICE study 2
- Chronic kidney disease
- Goto Shin
- 2019-07-26
Other
- Research study of QOL with leukotriene receptor antagonist ,pranlukast in asthmatic patients by use of Asthma Health Questionnaire-Japan QOL (AHQ-JAPAN QOL)
- Asthma
- Asthma QOL Research Study Group
- 2007-06-01
Recruiting
- Renal Anemia Treatment with Roxadustat for Non-dialysis Patients with Lower Extremity Artery Disease: The REFINE trial
- lower extremities artery disease, renal anemia
- Ueki Yasushi
- 2023-12-12
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Other
- Randomized, double-blind, placebo-controlled study of AMG0001(HGF plasmid) for patients with arteriosclerosis obliterans
- Arteriosclerosis obliterans
- Anges MG, Inc.
- 2007-06-04
Other
- Randomized, controlled trial of early intervention with pranlukast for prevention of bronchial asthma in infants with wheezy bronchitis and atopy
- Infants between 1 and 3 years old, who have severe atopy defined by class 2 and more of Ig E to food and/or environment allergens and history of wheezy bronchitis twice.
- Japanese Society of Pediatric Allergy and Clinical Immunology
- 2007-04-01